Debra Apruzzese

Board Member @ Strategikon Pharma arrow icon

About Debra Apruzzese

Debra Apruzzese is a Board Member and the President of Axia11G Consulting Group, LLC, with extensive experience in senior executive roles at Merck & Co, Inc.

Known information

Debra Apruzzese serves as a Board Member and is currently the President of Axia11G Consulting Group, LLC. She has a distinguished career at Merck & Co, Inc., where she held various senior executive positions. At Merck, she oversaw performance improvement and integration activities for mergers and acquisitions, streamlined manufacturing operations, and enhanced R&D productivity. Her leadership roles spanned Operations Management, Human Resources, Business Development, and Strategic Planning. As Vice President of MRL Business Performance Management, she led transformative initiatives in Clinical Data Management and spearheaded projects to enhance Discovery, Pre-clinical, and Clinical Development. Additionally, she developed the Biotech deal acceleration process and led strategic business teams in collaboration with Oncology and Neuroscience Therapeutic areas. At Axia11G Consulting Group, LLC, she leads a team that provides effective solutions and strategies to enhance the financial and operational well-being of organizations, focusing on the Healthcare, Life Sciences, and Environmental sectors.

About Strategikon Pharma

Strategikon Pharma offers Clinical Maestro, a SaaS platform for managing clinical trial transactions and financial performance, used by leading biopharmaceutical sponsors and CROs.

report flag Report inaccurate information

People similar to Debra Apruzzese

Mark Weinstein

Chairman of the Board, former CEO BioClinica @ Strategikon Pharma

Mark Weinstein is the Chairman of the Board and former CEO of BioClinica, who significantly grew the company's revenue during his tenure.

Christopher Codeanne is a board member with extensive experience in business and financial operations, having held key roles in various organizations including Cornerstone Therapeutics Inc., Oxford Performance Materials, and Premier Research.

Robert Hess is a board member, angel investor, and patent attorney with a focus on pharmaceuticals, medtech, and B2B SaaS. He is a member of several angel groups and serves as co-chair of the Digital Health committee at Life Science Angels.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free